president, different measures were determined for gradual implementation (support of local medicinal products development, amendments to legislation in registration, pricing and circulation of pharmaceuticals and so…
reporting and evaluating suspected ADRs during the development and following the marketing authorisation of medicinal products in the EEA. EudraVigilance is also one of the main pillars of the European ... Furthermore…
assessment, control, communication and review of risks to the quality of the medicinal product. It can be applied both proactively and retrospectively. Therefore, the objective is not just to identify ... other areas of…
Europe, herbal medicinal drugs (HMPs), and food, including food supplements, have different legal definitions (Directive 2001/83/EC and Regulation 1924/2006, respectively). They therefore must be clearly separated. HMPs…
paradigm shift in treatment approach. Scientific and technological advances lead to another type of medicinal product: precision medicine is targeted (‘personalized’) medicine, as opposed to small molecule onesize- fits…
current state of the art of such plasmas as pharmaceutics products or therapeutic tools in Medicine with a light on a selection of forefront researches particularly in the field
purpose of the article is medicinal products as an object of economic, civil and administrative legal relations: International standards and ways of improvement. Methods: The methodological basis of the study ... legal…
Advanced Therapy Medicinal Products (ATMPs) represent a transformative frontier in medicine, offering innovative solutions for previously untreatable diseases. These products, which include gene therapies, cell…
Active Pharmaceutical Ingredients (APIs) are fundamental constituents of medicinal products, serving as the primary agents responsible for therapeutic effects. This abstract delves into the significance of APIs in…
requirement for total disclosure sets too high a barrier to consent, particularly in Advanced Medicinal Products (AMP). In the early stage development of AMP investigators and sponsors may not have
Paediatric Strategy Forum concentrated on AML in children and adolescents. Results: Eight classes of medicinal products were bandied at the Forum FLT3, IDH1 & 2, checkpoint, cell signalling and HDAC impediments ... high…
Exploration on herbal medicinal products is decreasingly published in “Western ” scientific journals devoted primarily to conventional drugs. Publications are concerned substantially not only on the issues of safety and…